Loss of high affinity transforming growth factor-β1 (TGF-β1) binding to a nephritogenic T cell results in absence of growth inhibition by TGF-β1 and augmented nephritogenicity

Journal of Immunology

Volumn 156, Issue 8, 1996, Pages 3009-3016

  Bailey, Naila C ^a   Frishberg, Yaacov ^a   Kelly, Carolyn J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH INHIBITOR; IMMUNOSUPPRESSIVE AGENT; TRANSFORMING GROWTH FACTOR BETA;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BINDING SITE; CELL CLONE; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; INTERSTITIAL NEPHRITIS; METABOLISM; MOLECULAR GENETICS; MOUSE; MOUSE STRAIN; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BINDING SITES; CLONE CELLS; GROWTH INHIBITORS; IMMUNITY, NATURAL; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED STRAINS; MOLECULAR SEQUENCE DATA; MUTATION; NEPHRITIS, INTERSTITIAL; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030584918     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Kulkarni, A. B , C. G. Huh, D. Becker, A Geiser, M. Lyght, K. C Flanders, A B Roberts, M. B. Sporn, J M. Ward, and S Karlsson. 1993 Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl. Acad. Sci. USA 90.770.
2. Kuhn, R., J. Lohler, D Rennick, K. Rajewsky, and W. Muller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263
3. Sadlack, B., H. Merz, H. Schorle, A. Schimpl, A. C. Feller, and I. Horak 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene Cell 75:253
4. Chen. Y., V. K. Kuchroo, J Inobe, D A Hafler, and H. L Weiner. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis Science 265.1237.
5. Yamamoto, T , N A. Noble, D E. Miller, and W. A. Border. 1994. Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis Kidney Int. 45:916.
6. Yamamoto, T., T Nakamura. N A. Noble, E Ruoslahti, and W. A Border. 1993. Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl. Acad. Sci. USA 90:1814.
7. Border, W. A . S. Okuda, L R Languino, M B Sporn, and E Ruoslahti 1990 Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature 346.371.
8. Border, W. A., N. A. Noble. T. Yamamoto, J R Harper, Y U. Yamaguchi, M. D. Pierschbacher, and E, Ruoslahti 1992 Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 360: 361.
9. Bohle, A., S. Mackensen-Haen, and H von Gise 1987 Significance of tubulointerstitial changes in the renal cortex for excretory function and concentration ability of the kidney. a morphometric contribution Am. J. Nephrol 7:421
10. + effector T cell that mediates destructive tubulointerstitial injury. J. Immunol. 136.526.
11. Neilson, E. G , and S M Phillips. 1982 Murine interstitial nephritis. I. Analysis of disease susceptibility and its relationship to pleiomorphic gene products defining both immune-response genes and a restrictive requirement for cytotoxic T cells at H-2k J. Exp. Med. 155:1075.
12. Neilson, E. G., E McCafferty, R Mann, L. Richard, and M. Clayman 1985. Murine interstitial nephritis. III The selection of phenotypic (Lyt and L3T4) and idiotypic (RE-Id) T cell preferences by genes in Igh-1 and H-2k characterizes the cell-mediated potential for disease expression: susceptible mice provide a unique effector T cell repertoire in response to tubular antigen. J. Immunol. 134:2375.
13. Zakheim, B., E. McCafferty, R. Mann, S. M. Phillips. M. Clayman, and E. G. Neilson. 1984. Murine interstitial nephritis. II The adoptive transfer of disease with immune T lymphocytes produces a phenotypically complex interstitial lesion. J. Immunol 133.234.
14. - T cell line that mediates murine interstitial nephntis. J. Clin. Invest. 88 408.
15. Meyers, C. M , J. B. Kopp, P. Klotman, and C. J Kelly. 1992. Renal antigen-specific T cell clones elicit distinet patterns of interstitial injury and TGF-b expression J. Am. Soc. Nephrol. 3:604
16. Neilson, E. G., M J Sun, C. J Kelly, W H Hines, T. P. Haverty, M. D. Clayman, and N. E. Cooke. 1991 Molecular characterization of a major nephritogenic domain in the autoantigen of anti-tubular basement membrane disease Proc. Natl. Acad. Sci. USA 88:2006
17. Meyers, C. M., and C. J. Kelly. 1994. Immunoregulation and TGF-β1. Suppression of a nephritogenic murine T cell clone. Kidney Int. 46:1295.
18. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
19. Scatchard, G. 1949. The attractions of proteins for small molecules and ions. Ann. NY Acad. Sci. 51:660.
20. Sanger, F., and A. R. Coulson. 1975. A rapid method of determining sequences in DNA by primed synthesis with DNA polymerase. J. Mol. Biol 94:441.
21. Southern, E. M. 1975. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:503.
22. Lawler, S., A. F. Candia, R. Ebner, L. Shum, A. R. Lopez, H. L. Moses, C. V. E. Wright, and R Derynck. 1994. The murine type II TGF-beta receptor has a coincident embryonic expression and binding preference for TGF-beta-1. Development 120:165.
23. Siepl, C., U. V. Malipiero, and A. Fontana. 1991. Transforming growth factor-beta (TGF-beta)-resistant helper T lymphocyte clones show a concomitant loss of all three types of TGF-beta receptors. J. Immunol. 146:3063.
24. Kimchi, A., X. F. Wang, R. A. Weinberg, S. Cheifetz, and J. Massague. 1988. Absence of TGF-beta receptor and growth inhibitory responses in retinoblastoma cells. Science 240:196.
25. Massague, J., and B Like. 1985 Cellular receptors for type beta transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines. J. Biol. Chem. 260:2636.
26. Kehrl, J. H., A. B. Roberts, L. M. Wakefield, S. Jakowlew, M. B. Sporn, and A. S. Fauci. 1986. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. J. Immunol. 137:3855.
27. Kehrl, J. H., L. M. Wakefield, A. B. Roberts, S. Jakowlew, M. Alvarez-Mon, R. Derynck, M. B. Sporn, and A. S. Fauci. 1986. Production of transforming growth factor-beta by human T lymphocytes and its potential role in the regulation of T cell growth J Exp. Med. 163:1037.
28. Wrana, J. L., L. Attisano, J. Carcamo, A. Zentella, J. Doody, M. Laiho, X.-F Wang, and J. Massague. 1992 TGF-beta signals through a heteromeric protein kinase receptor complex. Cell 71:1003.
29. Laiho, M., F. M. B. Weis, and J. Massague. 1990. Concomitant loss of transforming growth factor (TGF)-beta receptor types I and II in TGF-beta-resistant cell mutants implicates both receptor types in signal transduction. J. Biol. Chem. 265:18518.
30. Franzen, P., P ten Dijke, H. Ichijo, H. Yamashita, P. Schulz, C.-H. Heldin, and K. Miyazono. 1993. Cloning of a TGF-beta type I receptor that forms a heteromeric complex with the TGF-beta type II receptor. Cell 75:681.
31. Bassing, C H., J. M Yingling, D.J. Howe, T Wang, W W. He, M. L Gustafson, P, Shah, P. K. Donahoe, and X.-F. Wang. 1994. A transforming growth factor-beta type I receptor that signals to activate gene expression. Science 263:87.
32. Tomoda, T , T. Kudoh, T. Noma. A. Nakazawa, M.-A. Muramatsu, and K -I. Arai. 1994 Molecular cloning of a mouse counterpart for human TGF-beta type I receptor. Biochem. Biophys. Res. Commun. 198:1054.
33. Okayama, H., D. T. Curiel, M. L Brandy, M. D. Holmes, and R. G. Crystal. 1989. Rapid, nonradioactive detection of mutations in the human genome by allele-specific amplification. J. Lab. Clin. Med. 114:105
34. Newton, C. R., A. Graham, L. E. Heptinstall, S. J. Powell, C. Summers, N. Kalsheker, J. C. Smith, and A F. Markham. 1989 Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 17:2503.
35. Wu, D. Y., L. Ucozzoli, B. K. Pal, and R B. Wallace. 1989. Allele-specific enzymatic amplification of beta-globin genomic DNA for diagnosis of sickle cell anemia. Proc. Natl. Acad. Sci USA 86:2757.
36. Cheifetz, S., J. A. Weatherbee, M. L. S. Tsang, J. K. Anderson, J. E. Mole, R. Lucas, and J. Massague. 1987 The transforming growth factor-beta system, a complex pattern of cross-reactive ligands and receptors. Cell 48 409.
37. Frolik, C. A., L. M. Wakefield, D M. Smith, and M. B. Sporn 1984. Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts. J. Biol. Chem. 259:10995.
38. Ellingsworth, L., D. Nakayama, I. Dasch, P Segarini, P. Camllo, and W Waegell. 1989. Transforming growth factor-beta-1 (TGF-beta-1) receptor expression on resting and mitogen-activated T cells J. Cell Biochem. 39:489.
39. Ruscetti, F. W., and M. A Palladino. 1991. Transforming growth factor-beta and the immune system. Prog. Growth Factor Res. 3.159
40. Wakefield, L. M , D. M. Smith, T. Masui, C. Harris, and M B. Sporn. 1987. Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblast. J Cell Biol 105:965.
41. Lin, H. Y., X.-F. Wang, E. Ng-Eaton, R. A. Weinberg, and H. F Lodish 1992. Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase. Cell 68:775
42. Massague, J 1990. The transforming growth factor-beta family. Annu. Rev. Cell Biol. 6:597.
43. Ranges, G. E., I S. Figari, T Espevik, and M. A. Palladino. 1987. Inhibition of cytotoxic T cell development by transforming growth factor-beta and reversal by recombinant tumor necrosis factor alpha. J. Exp. Med. 166:991.
44. Yamamoto, H., M. Hirayama, C. Genyea, and J. Kaplan. 1994. TGF-beta mediates natural suppressor activity of IL-2-activated lymphocytes J. Immunol. 152. 3842.
45. Espevik, T., I. S. Figari, M. R Shalaby, G. A. Lackides, G. D. Lewis, H M. Shepard, and M. A. Palladino. 1987. Inhibition of cytokine production by cyclosponn A and transforming growth factor-beta. J. Exp. Med. 166.571
46. Schluesener, H. J., and O. Lider. 1989. Transforming growth factor-beta 1 and beta 2 cytokines with identical immunosuppressive effects and a potential role in the regulation of autoimmune T cell function. J. Neuroimmunol. 24:249.
47. Chantry, D , M. Turner, E. Abney, and M. Feldmann. 1989. Modulation of cytokine production by transforming growth factor-beta. J. Immunol. 142.4295
48. Meyers, C. M., and C. J. Kelly. 1994. Inhibition of murine nephritogenic effector T cells by a clone-specific suppressor factor. J. Clin. Invest. 94-2093.
49. Boyd, F. T., and J. Massague. 1989. Transforming growth factor-beta inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor. J. Biol. Chem. 264:2272.
50. Lopez-Casillas, F., H. M. Payne, J. L. Andres, and J. Massague. 1994 Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites. J. Cell Bull. 124:557.
51. Wang, X.-F, H. Y. Lin, E. Ng-Eaton, J. Downward, H. F. Lodish, and R A Weinberg 1991. Expression cloning and characterization of the TGF beta type III receptor. Cell 67:797.
52. Attisano, L., J. Carcamo, F. Ventura, F. M. B. Weis, J. Massague, and J L. Wrana. 1993. Identification of human activin and TGF-beta type I receptors that form heteromeric kinase complexes with type II receptors. Cell 75.671.
53. Ebner, R , R.-H. Chen, L Shum, S. Lawler, T F. Zioncheck, A. Lee, A. R Lopez, and R. Derynck. 1993. Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor. Science 260:1344.
54. Wrana, J L., L. Attisano, R. Wieser, F. Ventura, and J. Massague. 1994. Mechanism of activation of the TGF-beta receptor. Nature 370:341
55. Chen, F , and R. A. Weinberg. 1995. Biochemical evidence for the autophosphorylation and transphosphorylation of transforming growth factor beta receptor kinases. Proc. Natl Acad. Sci. USA 9240:1565.
56. Chen, R. H., H. L. Moses, E. M. Maruoka, R Derynck, and M Kawabata. 1995. Phosphorylation-dependent interaction of the cyloplasmic domains of the type I and type II transforming growth factor-beta receptors. J. Biol. Chem. 270:12235.
57. Shiang, R., L. M Thompson, Y.-Z. Zhu, D. M. Church, T. J. Fielder, M. Bocian, S. T. Winokur, and J. J. Wasmuth. 1994. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78:335.
58. Rousseau, F., J. Bonaventure, L. Legeai-Mallet, A. Pelet, J.-M. Rozet, P. Maroteaux, M. le Merrer. and A. Munnich. 1994. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371:252.
59. Ullrich, A., and J. Schlessinger. 1990. Signal transduction by receptors with tyrosine kinase activity. Cell 61:203.
60. Choi, M. E., E.-G. Kim, Q. Huang. and B. J. Ballermann. 1993. Rat mesangial cell hypertrophy in response to transforming growth factor-β1. Kidney Int 44: 948.
61. Inagaki, M., Z. Wang, and B I. Can. 1994. Transforming growth factor beta 1 selectively increases gene expression of the serine/threonine kinase receptor 1 in human hepatoma cell lines. Cell Struct. Funct. 19.305.
62. Markowitz, S., J. Wang, L. Myeroff, R. Parsons, L Sun. J Lutterbaugh, R. S. Fan, E Zborowska, K. W Kinzler, B. Vogelstein, M. Brattain, and J. K V. Willson. 1995. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268:1336.
63. Wang, J., L. Sun, L. Myeroff, X. Wang, L. E. Gentry, J. Yang, J Liang, E Zborowska, S. Markowitz, J. K. V. Willson, and M. G. Brattain. 1995. Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J. Biol. Chem. 270:22044.
64. ten Dijke, P., H. Yamashita, H. Ichijo, P. Franzen, M. Laiho, K Miyazono. and C.-H. Heldin. 1994. Characterization of type I receptors for transforming growth factor-beta and activin. Science 264:101.
65. Penton, A., Y. Chen, K. Stachling-Hampton, J L. Wrana, L. Attisano, J. Szidonya, J. A. Cassill, J. Massague, and F. M. Hoffmann 1994 Identification of two bone morphogenetic protein type I receptors in Drosophila and evidence that Brk25D is a decapentaplegic receptor. Cell 78:239.
66. Dewulf, N., K Verschueren, O. Lonnoy, A Moren, S. Grimsby, K. Vande Spiegle, K. Miyazono, D. Huylebroeck, and P. ten Dijke 1995. Distinct spatial and temporal expression patterns of two type I receptors for bone morphogenetic proteins during mouse embryogenesis. Endocrinology 136:2652